SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-022942
Filing Date
2020-05-07
Accepted
2020-05-07 16:38:15
Documents
59
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q zfgn-10q_20200331.htm 10-Q 1888342
2 EX-31.1 zfgn-ex311_11.htm EX-31.1 7967
3 EX-31.2 zfgn-ex312_6.htm EX-31.2 7964
4 EX-32.1 zfgn-ex321_10.htm EX-32.1 12968
  Complete submission text file 0001564590-20-022942.txt   6229281

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT zfgn-20200331.xml EX-101.INS 1353224
6 XBRL TAXONOMY EXTENSION SCHEMA zfgn-20200331.xsd EX-101.SCH 41613
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE zfgn-20200331_cal.xml EX-101.CAL 47388
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE zfgn-20200331_def.xml EX-101.DEF 125691
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE zfgn-20200331_lab.xml EX-101.LAB 328618
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zfgn-20200331_pre.xml EX-101.PRE 247989
Mailing Address 3 CENTER PLAZA SUITE 610 BOSTON MA 02108
Business Address 3 CENTER PLAZA SUITE 610 BOSTON MA 02108 617-622-4003
ZAFGEN, INC. (Filer) CIK: 0001374690 (see all company filings)

IRS No.: 203857670 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36510 | Film No.: 20857084
SIC: 2834 Pharmaceutical Preparations